Sessions

Unlocking the Potential of Advanced Therapies Through Collaborations
Technology, Disruptive Innovation and Partnerships that are Revolutionizing How Medicines Are Made
Overcoming Scale Up Process Development Challenges for Pluripotent Stem Cell Derived Therapies
Future-Proofing Cell Therapy Production
Add It Up: 3 Things to Consider for Capacity Expansion
Why So Shy? Implementing Disruptive Technologies with Confidence in Cell Therapy

Unlocking the Potential of Advanced Therapies Through Collaborations

26 Jan 2022
12:30
Briefing Room
SPONSORED BY
Terumo Blood and Cell Technologies

What will be discussed:

  • Top challenges faced by drug developers in academia and biotech
  • Lessons learnt from translating innovation into therapies
  • How different stakeholders can work together to advance life changing therapies into the market

Moderator
Delara Motlagh, General Manager, Cell Therapy Technologies, Terumo BCT

Panellists

Alex Klarer, Head of Cell Therapy, BioCentriq

Tifany Rau, Owner and Principal Consultant, Rau Consulting

Krishendu Roy, Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT), Georgia Tech (Live Streamed)

Speakers

Delara Motlagh
General Manager, Cell Therapy Technologies
Terumo Blood and Cell Technologies
Krishendu Roy
Robert A. Milton Chair Professor, Director, NSF ERC on Cell Manufacturing Technologies (CMaT)
Georgia Tech
Tiffany Rau
Owner and Principal Consultant
Rau Consulting